| Title : Metabolic reprogramming based on RNA sequencing of gemcitabine-resistant cells reveals the FASN gene as a therapeutic for bladder cancer - Zhou_2024_J.Transl.Med_22_55 |
| Author(s) : Zhou L , Du K , Dai Y , Zeng Y , Luo Y , Ren M , Pan W , Liu Y , Zhang L , Zhu R , Feng D , Tian F , Gu C |
| Ref : J Transl Med , 22 :55 , 2024 |
| Abstract : Zhou_2024_J.Transl.Med_22_55 |
| ESTHER : Zhou_2024_J.Transl.Med_22_55 |
| PubMedSearch : Zhou_2024_J.Transl.Med_22_55 |
| PubMedID: 38218866 |
Zhou L, Du K, Dai Y, Zeng Y, Luo Y, Ren M, Pan W, Liu Y, Zhang L, Zhu R, Feng D, Tian F, Gu C (2024)
Metabolic reprogramming based on RNA sequencing of gemcitabine-resistant cells reveals the FASN gene as a therapeutic for bladder cancer
J Transl Med
22 :55
Zhou L, Du K, Dai Y, Zeng Y, Luo Y, Ren M, Pan W, Liu Y, Zhang L, Zhu R, Feng D, Tian F, Gu C (2024)
J Transl Med
22 :55